3.0.0 4733 2023-01-11T13:39:12Z 2023-01-11T13:39:12Z House HR 2017-12-21 115 [Congressional Record Volume 163, Number 209 (Thursday, December 21, 2017)]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. WELCH:H.R. 4733.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18: The Congress shall havePower To . . . make all Laws which shall be necessary andproper for carrying into Execution the foregoing Powers, andall other Powers vested by this Constitution in theGovernment of the United States, or in any Department orOfficer thereof.____________________[Page H10421]]]> hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2018-01-03T21:37:24Z Referred to 2017-12-21T14:03:20Z hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2017-12-22T17:44:14Z Referred to 2017-12-21T14:03:10Z hsbu00 Budget Committee House Standing Referred to 2017-12-21T14:03:15Z Opioid Emergency Response Act 115 5531 HR 2018-05-22 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. Related bill CRS Opioids and STOP Pain Initiative Act 115 2260 S 2017-12-21 Read twice and referred to the Committee on Finance. Identical bill CRS 2018-01-03 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-12-22 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2017-12-21 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2017-12-21 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsbu00 Budget Committee 2017-12-21 Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Budget, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2017-12-21 Introduced in House IntroReferral Intro-H 9 Library of Congress 2017-12-21 Introduced in House IntroReferral 1000 9 Library of Congress W000800 Rep. Welch, Peter [D-VT-At Large] Peter Welch D VT N M001180 Rep. McKinley, David B. [R-WV-1] David McKinley R WV B. 1 2017-12-21 True G000574 Rep. Gallego, Ruben [D-AZ-7] Ruben Gallego D AZ 7 2018-02-20 False K000389 Rep. Khanna, Ro [D-CA-17] Ro Khanna D CA 17 2018-02-20 False C001084 Rep. Cicilline, David N. [D-RI-1] David Cicilline D RI N. 1 2018-02-20 False K000210 Rep. King, Peter T. [R-NY-2] PETER KING R NY T. 2 2018-02-20 False E000179 Rep. Engel, Eliot L. [D-NY-16] ELIOT ENGEL D NY L. 16 2018-03-01 False L000557 Rep. Larson, John B. [D-CT-1] JOHN LARSON D CT B. 1 2018-03-01 False B000574 Rep. Blumenauer, Earl [D-OR-3] EARL BLUMENAUER D OR 3 2018-03-01 False E000215 Rep. Eshoo, Anna G. [D-CA-18] ANNA ESHOO D CA G. 18 2018-03-01 False R000606 Rep. Raskin, Jamie [D-MD-8] Jamie Raskin D MD 8 2018-03-01 False P000604 Rep. Payne, Donald M., Jr. [D-NJ-10] Donald Payne D NJ M. 10 2018-03-07 False L000397 Rep. Lofgren, Zoe [D-CA-19] ZOE LOFGREN D CA 19 2018-03-07 False K000382 Rep. Kuster, Ann M. [D-NH-2] Ann Kuster D NH M. 2 2018-03-07 False D000533 Rep. Duncan, John J., Jr. [R-TN-2] JOHN DUNCAN R TN J. 2 2018-03-07 False D000624 Rep. Dingell, Debbie [D-MI-12] Debbie Dingell D MI 12 2018-03-07 False M001195 Rep. Mooney, Alexander X. [R-WV-2] Alexander Mooney R WV X. 2 2018-03-09 False C001048 Rep. Culberson, John Abney [R-TX-7] JOHN CULBERSON R TX ABNEY 7 2018-03-26 False M001196 Rep. Moulton, Seth [D-MA-6] Seth Moulton D MA 6 2018-03-26 False B001285 Rep. Brownley, Julia [D-CA-26] Julia Brownley D CA 26 2018-03-26 False E000293 Rep. Esty, Elizabeth H. [D-CT-5] Elizabeth Esty D CT H. 5 2018-04-17 False B001278 Rep. Bonamici, Suzanne [D-OR-1] Suzanne Bonamici D OR 1 2018-04-17 False M000312 Rep. McGovern, James P. [D-MA-2] JAMES MCGOVERN D MA P. 2 2018-04-23 False L000588 Rep. Lamb, Conor [D-PA-18] Conor Lamb D PA 18 2018-04-27 False J000297 Rep. Jenkins, Evan H. [R-WV-3] Evan Jenkins R WV H. 3 2018-07-23 False O000170 Rep. O'Rourke, Beto [D-TX-16] Beto O'Rourke D TX 16 2018-07-23 False C001068 Rep. Cohen, Steve [D-TN-9] Steve Cohen D TN 9 2018-07-23 False H001068 Rep. Huffman, Jared [D-CA-2] Jared Huffman D CA 2 2018-07-26 False L000559 Rep. Langevin, James R. [D-RI-2] JAMES LANGEVIN D RI R. 2 2018-09-04 False Health Charitable contributions Congressional oversight Department of Health and Human Services Drug therapy Drug trafficking and controlled substances Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Income tax credits Medical research National Institutes of Health (NIH) Prescription drugs Research administration and funding Research and development Social work, volunteer service, charitable organizations User charges and fees Health 00 2017-12-21 Introduced in House 2018-05-11T15:15:59Z Opioids and STOP Pain Initiative Act

This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:

  • understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
  • improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
  • supporting the Federal Pain Research Strategy.

NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.

]]> Opioids and STOP Pain Initiative Act Display Title Opioids and STOP Pain Initiative Act Short Titles as Introduced Opioids and STOP Pain Initiative Act Official Title as Introduced To establish and fund an Opioids and STOP Pain Initiative to expand, intensify, and coordinate fundamental, translational, and clinical research of the National Institutes of Health with respect to opioid abuse, the understanding of pain, and the discovery and development of safer and more effective treatments and preventive interventions for pain. Introduced in House 2017-12-21T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115hr4733ih/xml/BILLS-115hr4733ih.xml 2018-01-03 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.